CollPlant Biotechnologies (CLGN) Retained Earnings (2018 - 2025)

CollPlant Biotechnologies' Retained Earnings history spans 8 years, with the latest figure at -$124.8 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 10.14% year-over-year to -$124.8 million; the TTM value through Dec 2025 reached -$124.8 million, down 10.14%, while the annual FY2025 figure was -$124.8 million, 10.14% down from the prior year.
  • Retained Earnings reached -$124.8 million in Q4 2025 per CLGN's latest filing, down from -$113.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$72.8 million in Q4 2021 to a low of -$124.8 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$99.5 million, with a median of -$96.7 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: increased 0.32% in 2021, then decreased 23.25% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$72.8 million in 2021, then dropped by 23.25% to -$89.7 million in 2022, then dropped by 7.82% to -$96.7 million in 2023, then dropped by 17.17% to -$113.4 million in 2024, then dropped by 10.14% to -$124.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Retained Earnings are -$124.8 million (Q4 2025), -$113.4 million (Q4 2024), and -$96.7 million (Q4 2023).